NCT04939090 2026-03-04
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
Clinical Trials
9 trialsNCT06995508 2026-02-17
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Roswell Park Cancer Institute
Phase 2 Recruiting
NCT06200181 2026-02-13
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT03118986 2025-10-08
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The Hospital for Sick Children
Phase 2 Recruiting
NCT06588413 2024-11-22
FONDO-LOW
Augusta University
Phase 3 Recruiting
NCT06517199 2024-07-24
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Mahidol University
Phase 3 Recruiting
NCT06500234 2024-07-15
Nutrition Impact on Immunotherapy of Cancer
Qingdao Central Hospital
Phase 3 Recruiting
NCT06338683 2024-03-29
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Qinghai Red Cross Hospital
Phase 3 Recruiting